The Application of Digital PCR as a Reference Measurement Procedure to Support the Accuracy of Quality Assurance for Infectious Disease Molecular Diagnostic Testing
Authors:
- Samreen FalakSFSamreen Falak
- Denise M O’sUllivanDODenise M O’sUllivan
- Megan H ClevelandMCMegan H Cleveland
- Simon CowenSCSimon Cowen
- Eloise J BusbyEBEloise J Busby
- Alison S DevonshireADAlison S Devonshire
- Esmeralda ValienteEVEsmeralda Valiente
- Gerwyn M JonesGJGerwyn M Jones
- Martin KammelMKMartin Kammel
- Mojca MilavecMMMojca Milavec
- Laura VierbaumLVLaura Vierbaum
Open Access
- 26 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 71 (3) , 378-386
Abstract
Background: Nucleic acid amplification tests (NAATs) assist in the diagnosis of numerous infectious diseases. They are typically sensitive and specific and can be quickly developed and adapted. Far more challenging is the development of standards to ensure NAATs are performing within specification; reference materials take time to develop and suitable reference measurement procedures (RMPs) have not been available. This study investigated digital PCR (dPCR) RMP delivery of traceability for NAAT external quality assessment (EQA). Methods: Three National Metrology Institutes (NMIs) applied reverse transcription (RT)-dPCR as a candidate RMP to estimate the RNA quantity in 32 independent severe acute respiratory syndrome coronavirus 2 materials. The results were combined to value assign the respective materials: 21 materials were used in 6 rounds of EQA over 17 months for 61 laboratories for COVID-19 testing results compared with reference values. Results: The agreement between the 3 NMIs showed <2-fold difference between laboratories. EQA laboratory reverse transcription quantitative PCR (RT-qPCR) values estimation of viral RNA quantity showed good median agreement with RT-dPCR reference value; however, RT-qPCR differences were generally between 10- and 50-fold between laboratories. Conclusion: This work demonstrates how RT-dPCR can provide reference values for whole virus materials for NAAT quality assurance. RT-dPCR values guided EQA control material selection and provided EQA participants with traceability to RNA copy number delivered through the RMP. This approach can be used to support routine reference material use as well as to standardize quality assurance for NAATs where established reference materials are not available, such as in disease outbreaks.Keywords
This publication has 18 references indexed in Scilit:
- Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious diseaseMolecular Aspects of Medicine, 2024
- Development of highly accurate digital PCR method and reference material for monkeypox virus detectionAnalytical and Bioanalytical Chemistry, 2023
- Establishment and evaluation of digital PCR methods for HER2 copy number variation in breast cancerAnalytical and Bioanalytical Chemistry, 2022
- Accurate quantification of SARS-CoV-2 RNA by isotope dilution mass spectrometry and providing a correction of reverse transcription efficiency in droplet digital PCRAnalytical and Bioanalytical Chemistry, 2022
- The performance of human cytomegalovirus digital PCR reference measurement procedure in seven external quality assessment schemes over four yearsMethods, 2022
- An assessment of the reproducibility of reverse transcription digital PCR quantification of HIV-1Methods, 2022
- Diagnostics for COVID-19: moving from pandemic response to controlThe Lancet, 2021
- Highly Reproducible Absolute Quantification of Mycobacterium tuberculosis Complex by Digital PCRAnalytical Chemistry, 2015
- Considerations for accurate gene expression measurement by reverse transcription quantitative PCR when analysing clinical samplesAnalytical and Bioanalytical Chemistry, 2014
- Development of working reference materials for clinical virologyJournal of Clinical Virology, 2008